Detalhe da pesquisa
1.
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements.
Hepatology
; 79(4): 869-881, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916970
2.
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Lancet Oncol
; 24(3): 297-306, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739879
3.
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors.
Neuroendocrinology
; 112(6): 537-546, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348346
4.
Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE).
Neuroendocrinology
; 106(1): 38-46, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28152531
5.
Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study.
Ann Intern Med
; 162(10): 682-9, 2015 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25984844
6.
Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort.
Dig Liver Dis
; 54(3): 391-399, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34384712
7.
Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study.
J Clin Endocrinol Metab
; 106(4): e1673-e1682, 2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382891
8.
First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.
Ann Pharmacother
; 44(12): 1998-2000, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21098750
9.
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study.
Dig Liver Dis
; 52(3): 347-350, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899122
10.
Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE).
United European Gastroenterol J
; 7(8): 1102-1112, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31662867
11.
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study.
Dig Liver Dis
; 50(2): 195-198, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29258812
12.
Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).
Endocrine
; 57(3): 504-511, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664309
13.
Parietal cell antibodies: evolution of plasma vitamin B12 during oral supplementation to differentiate true and false positives for pernicious anemia.
Pol Arch Intern Med
; 130(9): 813-815, 2020 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32621669